ABOUT US
Nativus Group unites companies working in the field of novel medicinal and therapeutic compound research, development, production and marketing.
We are NATIVUS
We are a group of companies dedicated to the advancement of pharmaceutical, wellness and cosmetics industries.
OUR WORK
Our work is focused on natural compounds found in plants that are finally regaining the well-deserved attention.
WE UNDERSTAND THE POTENTIAL
These compounds are only now coming into the spotlight and an overwhelming amount of scientific research indicates their vast potential to treat a number of the most pressing physical and mental ailments, including, among others, depression, anxiety, sleeplessness, pain and inflammation.
Group
Neurostrain is a biotechnology company developing naturally occurring active compounds intended for treatment of neurological ailments.
Nativus Trade markets and sells products developed and produced by Sanobiotec and Neurostrain. It is also developing an online sales and…
Sanobiotec is the research and development company of Nativus Group that identifies, develops and produces cannabinoids and flavonoids.
News & Media
Extracting cannabinoids at scale: how chromatography is paving the way for pure compounds
Therapeutic use of cannabis is a growing industry increasingly accepted by the medical community and general public — but that growth may be stopped if biopharma companies lack reliable methods to extract and purify potentially useful compounds from the plant. ... read more →
2020-12-16
Minor cannabinoid could “revolutionise” autism medication
Out of more than a hundred cannabinoids that have so far been identified in the cannabis sativa plant, the non-intoxicating cannabidivarin (CBDV)... read more →
2020-11-07
Firm creates rare cannabinoid used in chronic disease treatment
It is hoped that the pure ingredient will open up new research prospects for pharma, wellness industry, and other market players.
... read more →
2020-10-29
Exploring nuances of cannabinoid bioavailability: how water-soluble products can lead to greater absorption
The question of how to achieve greater bioavailability of cannabinoids has been one of the main challenges for researchers in the cannabis industry, and for a good reason.... read more →
2020-08-20
Biotechnology | Go Vilnius
If you check out the biotechnology sector overview on Go Vilnius website, you might notice a familiar name – #Sanobiotec among fellow biotech companies operating from Vilnius. ... read more →
2020-05-25
Sanobiotec taps into potential of minor cannabinoids
Sanobiotec aims to improve the technological processes for production of these compounds and leverage their therapeutic benefits for pharmaceuticals, wellness industry and treatment of progressive illnesses, such as cancer or Alzheimer’s.... read more →
2020-05-22